Register entry

Catalent Pharma Solution, LLC

Data as of · How to read this entry

Registered sites
0
Active NDC listings
12
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

12

12 active NDC listings: 12 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 7, EXPORT ONLY 5.

Dosage formNDCs
capsule12
RouteNDCs
Labeller name on the listingNDCs
catalent pharma solution, llc12
Catalogue

Marketed products

12
BrandGeneric nameForm / routeNDC
-Dextromethorphan Hydrobromidecapsule11014-0206DRUG FOR FURTHER PROCESSING
-Lomitapide Mesylatecapsule11014-0359DRUG FOR FURTHER PROCESSING
-Lomitapide Mesylatecapsule11014-0360DRUG FOR FURTHER PROCESSING
-Lomitapide Mesylatecapsule11014-0361DRUG FOR FURTHER PROCESSING
-Lomitapide Mesylatecapsule11014-0362DRUG FOR FURTHER PROCESSING
-Lomitapide Mesylatecapsule11014-0459EXPORT ONLY
-Lomitapide Mesylatecapsule11014-0460EXPORT ONLY
-Lomitapide Mesylatecapsule11014-0461EXPORT ONLY
-Tivozanibcapsule11014-0457DRUG FOR FURTHER PROCESSING
-Tivozanibcapsule11014-0458DRUG FOR FURTHER PROCESSING
-Tivozanibcapsule11014-0470EXPORT ONLY
-Tivozanibcapsule11014-0471EXPORT ONLY
Compare

Other companies listing lomitapide mesylate

Enquiry

Common questions

Is Catalent Pharma Solution, LLC FDA approved?
Catalent Pharma Solution, LLC holds no registered establishment of its own; 12 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Catalent Pharma Solution, LLC make?
12 products are listed under Catalent Pharma Solution, LLC in the openFDA NDC Directory, most often as capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.